NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Cambridge
State: Massachusetts
Zip:
Country: United States
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2023 | Series B | $0 |
Binney Street Capital Catalio Capital Management Gordon Freeman Invus Leaps by Bayer MPM Capital PagodaTree Partners Sanofi Ventures Sixty Degree Capital Binney Street Capital Catalio Capital Management Gordon Freeman Invus Leaps by Bayer MPM Capital PagodaTree Partners Sanofi Ventures Sixty Degree Capital |
1/2023 | Series B | 9 | $80M |
Binney Street Capital Catalio Capital Management Gordon Freeman Invus Leaps by Bayer MPM Capital PagodaTree Partners Sanofi Ventures Sixty Degree Capital Binney Street Capital Catalio Capital Management Gordon Freeman Invus Leaps by Bayer MPM Capital PagodaTree Partners Sanofi Ventures Sixty Degree Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|